Baphia nitida
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Baphia nitida |
|---|---|
| Iucn Redlist Category | Least Concern |
| Database Name | cmaup_plants;imppat_herbs;osadhi_herbs |
| Tropicos | http://www.tropicos.org/Name/13048033 |
| Pow | http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:480895-1 |
| Mpns Kew | https://mpns.science.kew.org/mpns-portal/plantDetail?plantId=669416&query=Baphia+nitida&filter=&fuzzy=false&nameType=all&dbs=wcsCmp |
| Synonyms | Baphia nitida, Baphida nitida, Baphia Nitida, Leguminosae, Fabaceae |
| Ipni Id | http://www.ipni.org/ipni/idPlantNameSearch.do?id=480895-1&back_page=%2Fipni%2FeditSimplePlantNameSearch.do%3Ffind_wholeName%3DBaphia%2Bnitida%26output_format%3Dnormal, NPO21005 |
| Plant List Id | http://www.theplantlist.org/tpl1.1/record/ild-7095 |
| Plant Name | Baphia nitida |
| Genus Tax Id | 48126 |
| Wfo | http://www.worldfloraonline.org/taxon/wfo-0000212016 |
| Disease Name | Metabolic disorder, Insomnia, Solid tumour/cancer, Osteoarthritis, General pain disorder, Chronic pain, Psoriasis, Crohn disease, Fungal infection, Acute myeloid leukaemia, Nicotine use disorder, Rheumatoid arthritis, Urinary tract infection, Multiple sclerosis, Obesity, Acute diabete complication, Diabetes mellitus, type unspecified, Inborn lipid metabolism error, Skin and skin-structure infection, Chronic kidney disease, Choreiform disorder, Visual system disease, Acute/subacute hepatic failure, Hypo-thyroidism, Lower limb mononeuropathy, Pain, unspecified, Attention deficit hyperactivity disorder, Atopic eczema, Type 2 diabetes mellitus, Irritable bowel syndrome, Cannabis use disorder, Indeterminate colitis, Migraine, Anorexia nervosa, Nausea/vomiting, Muscular dystrophy, Colorectal cancer, Knee osteoarthritis, Functional bladder disorder, Thyroid cancer, Asthma, Lupus erythematosus, Pulmonary hypertension, Cystic fibrosis, Sickle-cell disorder, Galactose-1-phosphate uridyltransferase deficiency, Essential hypertension, Malaria, Dental caries, Chronic arterial occlusive disease, unspecified, Cardiovascular disease, Small cell carcinoma of bronchus or lung, Sepsis, Allergic/hypersensitivity disorder, Mature T-cell lymphoma, Duchenne muscular dystrophy, COVID-19, Schizophrenia, Structural developmental anomaly of heart or great vessels, unspecified, Bipolar disorder, Mental/behavioural/neurodevelopmental disorder, Beta thalassaemia, Hepatocellular carcinoma, NOS, Other specified disorders of carbohydrate absorption or transport, coronary artery disease, Macular degeneration, Alzheimer disease, Melasma, Cataract, Xerostomia, Hepatic fibrosis/cirrhosis, Glioblastoma, primary, NOS, Neoplasms, Prostate cancer, Periodontal disease, Pre-eclampsia, Ischaemic heart diseases, unspecified, Disorders of methionine cycle or sulphur amino acid metabolism, Myocardial infarction, Alcoholic hepatitis, Tuberculosis of the respiratory system, Argininosuccinic aciduria, Congestive heart failure, Cardiac arrest, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Other specified malignant neoplasms ofcolon, Hepatocellular carcinoma of liver, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Adenocarcinoma of prostate, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Malignant neoplasms of thymus, Invasive carcinoma of breast, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Malignant neoplasms of adrenal gland, Gliomas of brain |
| Species Name | Baphia nitida |
| Genus Name | Baphia |
| Species Tax Id | 162666 |
| Disease Id | 5C50-5D2Z, 7A00-7A0Z, 2A00-2F9Z, FA00-FA05, 8.00E+43, MG30, EA90, DD70, 1F29-1F2F, 2A60, 6C4A, FA20, GC08, 8A40, 5B80-5B81, 5A2Y, 5A14, 5C52, 1F28-1G0Z, GB61, 8A01, 9E1Z, DB91, 5A00, 8C11, MG3Z, 6A05, EA80, 5A11, DD91, 6C41, DD72, 8A80, 6B80, MD90, 8C70, 2B91, FA01, GC50, 2D10, CA23, 4A40, BB01, CA25, 3A51, 5C51.40, BA00, 1F40-1F45, DA08.0, BD4Z, BA00-BE2Z, 2C25.1, 1G40-1G41, 4A80-4A8Z, 2A90, 8C70.1, 1D6Y, 6A20, LA8Z, 6A60, 6E20-6E8Z, 3A50.2, XH4W48, 5C61.Y, BA8Y-BA8Z, 9B75, 8A20, ED60.1, 9B10, DA02.1, DB93, XH0MB1, 2, 2C82, DA0C, JA24, BA6Z, 5C50.B, BA41-BA43, DB94.1, 1B10, 5C50.A0, BD10, MC82, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, 2C15, 2C12.01, 1F54, 2B72.0, 2D60.0, 2A81, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, 2B90.Y, 2C12.02, 2B70, 2C94.2, 1D82, 2C82.0, 2B72, 2C25.0, 2C76.Z, 2C27, 2C61, 1C62, 2A00.00, XH6153, 2C80.2, 2D11, 2A00.0 |
| Family Name | Leguminosae |
| Family Tax Id | 3803 |
| Group | Angiosperms |
- 1. (+)-Stephacidin A (PubChem CID: 16127922)
- 2. (-)-Sativan (PubChem CID: 170570)
- 3. (1r)-3,5,5-Trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-Tetramethyl-18-[(1r)-2,6,6-Trimethylcyclohex-2-En-1-Yl]octadeca-3,5,7,9,11,13,15,17-Octaen-1-Ynyl]cyclohex-3-En-1-Ol (PubChem CID: 101289802)
- 4. (1r,2r)-2-[(1e,3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15-Octaen-17-Ynyl]-1,3,3-Trimethylcyclohexane-1,2-Diol (PubChem CID: 163014206)
- 5. (1s,3ar,3bs,5ar,6r,8as,8bs)-3a,5a-Dimethyl-6-[(E,2r,5s)-5-Methylhept-3-En-2-Yl]-1,2,3,3b,4,5,6,7,8,8a,8b,9-Dodecahydroindeno[5,4-E]inden-1-Ol (PubChem CID: 163076709)
- 6. (2e,4e)-5-(1,3-Benzodioxol-5-Yl)-N-[(E)-10-Methylundec-5-Enyl]penta-2,4-Dienamide (PubChem CID: 90472536)
- 7. (2r)-2-[(2s,5r,9s)-2-[(S)-[(2r,5r)-5-[(1s,3r,5s)-1-[(2r,5r)-5-[(2r,3e,5e)-6-[(2r,3r,5s)-5-[(2r,3r,4r)-2-Hexadecanoyloxy-3-Hydroxy-4-Methyloxan-2-Yl]-3-Hydroxyoxolan-2-Yl]-2,4-Dimethylhexa-3,5-Dienyl]-5-Methyloxolan-2-Yl]-5-Methyl-2,8-Dioxabicyclo[3.2.1]octan-3-Yl]-2-Methyl-4-Oxooxolan-2-Yl]-Hydroxymethyl]-1,10-Dioxaspiro[4.5]decan-9-Yl]propanoic Acid (PubChem CID: 163101767)
- 8. (2r)-3-[(2s,6r,8r,11r)-2-[(E,2r)-4-[(2s,2'r,4r,4ar,6r,8as)-2-[(1s,3s)-1,3-Dihydroxy-3-[(2s,3r,6s)-3-Methyl-1,7-Dioxaspiro[5.5]undecan-2-Yl]propyl]-4-Hydroxy-3-Methylidenespiro[4a,7,8,8a-Tetrahydro-4h-Pyrano[3,2-B]pyran-6,5'-Oxolane]-2'-Yl]but-3-En-2-Yl]-11-Hydroxy-4-Methyl-1,7-Dioxaspiro[5.5]undec-4-En-8-Yl]-2-Hydroxy-2-Methylpropanoic Acid (PubChem CID: 163088763)
- 9. (2s,3s,4s)-4-[(2e,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916711)
- 10. (2s,3s,4s)-4-[(2z,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916712)
- 11. (2z,4e,6e,8e,10e,12e,14e,16e)-3-Hydroxy-19-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-1-[(1r,4s)-4-Hydroxy-1,2,2-Trimethylcyclopentyl]-4,8,13,17-Tetramethylnonadeca-2,4,6,8,10,12,14,16-Octaen-18-Yn-1-One (PubChem CID: 162912290)
- 12. (3e)-3-[(3,4-Dimethoxyphenyl)methylidene]-7-Methoxychromen-4-One (PubChem CID: 5783568)
- 13. (3r,3'r)-3'-(3-Hydroxyphenyl)-4-Methylspiro[1h-1,4-Benzodiazepine-3,2'-Oxirane]-2,5-Dione (PubChem CID: 92278353)
- 14. (3r,5s)-5-[(1r,4s,6r,7s,9r,10e,12r,17r,19r,20s,29s,32s)-9,32-Dihydroxy-6,10,13,19,20,32-Hexamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 162927161)
- 15. (3r,5s)-5-[(1s,4s,6s,7r,9r,10e,12s,17r,20r,29s,32s)-9,32-Dihydroxy-6,10,13,20,32-Pentamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 163190285)
- 16. (3s,8as)-3-[[(3r)-7,7-Dimethyl-3-(2-Methylbut-3-En-2-Yl)-2-Oxo-1h-Pyrano[2,3-G]indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 16127840)
- 17. (3s,8as)-3-[[2-(2,2-Dimethylbut-3-Enyl)-1h-Indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 163091236)
- 18. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 23428074)
- 19. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 162865461)
- 20. (5z)-5-((2e,4e,6e,8e)-11-((4r)-4-Hydroxy-2,6,6-Trimethyl-1-Cyclohexen-1-Yl)-2,9-Dimethyl-2,4,6,8-Undecatetraen-10-Yn-1-Ylidene)-3-((1e)-2-((1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo(4.1.0)hept-1-Yl)ethenyl)-2(5h)-Furanone (PubChem CID: 134741793)
- 21. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1r,2r,4s)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162883665)
- 22. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]ethenyl]furan-2-One (PubChem CID: 162880763)
- 23. (5z)-5-[(2e,4e,6e,8e)-11-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-2,9-Dimethylundeca-2,4,6,8-Tetraen-10-Ynylidene]-3-[(E)-2-[(1s,2s,4r)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162896470)
- 24. (E)-7-Methoxy-3-(4'-Methoxybenzylidene) Chroman-4-One (PubChem CID: 6507117)
- 25. 11,11-Dihydroxysaxitoxin (PubChem CID: 102411284)
- 26. 11beta-Hydroxy-N21-Sulfocarbamoylsaxitoxin (PubChem CID: 136045808)
- 27. 12-Deoxy-Sucutinirane A (PubChem CID: 44561378)
- 28. 19'-Hexanoyloxyisomytiloxanthin (PubChem CID: 16061209)
- 29. 2,4-Dodecadienamide, N-(2-Methylpropyl)-, (2e,4e)- (PubChem CID: 6443006)
- 30. 2,4-Pentadien-1-One, 5-(1,3-Benzodioxol-5-Yl)-1-(1-Piperidinyl)-, (2e,4e)- (PubChem CID: 4840)
- 31. 3,3'-Methylenebis(Tyrosine) (PubChem CID: 3082144)
- 32. 3-Methoxy-4-Hydroxy-Cinnamic Acid (PubChem CID: 709)
- 33. 5-[(1e)-Dodec-1-En-1-Yl]-2h-1,3-Benzodioxole (PubChem CID: 9922008)
- 34. 6-[(3,4-Dihydroxy-2-Methoxyphenyl)methyl]-5-(3,4-Dihydroxyphenyl)-9,10-Dihydroxy-1,3-Dimethoxybenzo[A]xanthen-2-One (PubChem CID: 102146090)
- 35. 6-Methoxypulcherrimin (PubChem CID: 44260092)
- 36. 6alpha,7beta-Diacetoxyvouacapane (PubChem CID: 24863610)
- 37. 7-Dehydrocholesterol (PubChem CID: 439423)
- 38. 7-Hydroxycadalene (PubChem CID: 608115)
- 39. [(2s,3r,4s,5r,6s)-6-[5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxochromen-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methyl (4r)-4-(2-Hydroxypropan-2-Yl)cyclohexene-1-Carboxylate (PubChem CID: 162849269)
- 40. Aegicerin (PubChem CID: 15558423)
- 41. Alloxanthin (PubChem CID: 6443740)
- 42. Alpha-Pinene, (+)- (PubChem CID: 82227)
- 43. Amarouciaxanthin B/sidnyaxanthin (PubChem CID: 16061221)
- 44. Anandamide (PubChem CID: 5281969)
- 45. Azaspiracid-3 (PubChem CID: 131842452)
- 46. Beta-Carotene (PubChem CID: 5280489)
- 47. Beta-Sitosterol (PubChem CID: 222284)
- 48. Betaine (PubChem CID: 247)
- 49. Cacticin (PubChem CID: 5318644)
- 50. Carvacrol (PubChem CID: 10364)
- 51. Cholesterol (PubChem CID: 5997)
- 52. Cid 101396440 (PubChem CID: 101396440)
- 53. Cid 154735200 (PubChem CID: 154735200)
- 54. Cid 162860366 (PubChem CID: 162860366)
- 55. Cid 162883225 (PubChem CID: 162883225)
- 56. Cid 162887352 (PubChem CID: 162887352)
- 57. Cid 162913940 (PubChem CID: 162913940)
- 58. Cid 162985394 (PubChem CID: 162985394)
- 59. Cid 162999788 (PubChem CID: 162999788)
- 60. Cid 163014543 (PubChem CID: 163014543)
- 61. Cid 163032184 (PubChem CID: 163032184)
- 62. Cid 163076592 (PubChem CID: 163076592)
- 63. Cid 17753955 (PubChem CID: 17753955)
- 64. Cid 23428237 (PubChem CID: 23428237)
- 65. Clemiscosin D (PubChem CID: 13965876)
- 66. D-Lactic Acid (PubChem CID: 61503)
- 67. Domoic Acid C5'-Diastereomer (PubChem CID: 5311075)
- 68. Epicatechin (PubChem CID: 72276)
- 69. Ergosterol (PubChem CID: 444679)
- 70. Halocynthiaxanthin (PubChem CID: 11966451)
- 71. Helichrysoside (PubChem CID: 5317991)
- 72. Hexadecanoic Acid Propylamide (PubChem CID: 10379895)
- 73. Himeic Acid A (PubChem CID: 11774903)
- 74. Himeic Acid B (PubChem CID: 21579676)
- 75. Himeic Acid C (PubChem CID: 21777983)
- 76. Hyperoside (PubChem CID: 5281643)
- 77. Ilepcimide (PubChem CID: 641115)
- 78. Isodomoic Acid F (PubChem CID: 101790920)
- 79. Isovouacapenol B (PubChem CID: 11812203)
- 80. Isovouacapenol C (PubChem CID: 3009285)
- 81. Isovouacapenol D (PubChem CID: 10905866)
- 82. Kaempferol (PubChem CID: 5280863)
- 83. Myricetin (PubChem CID: 5281672)
- 84. Mytiloxanthin (PubChem CID: 11365423)
- 85. N,n,n-Trimethylglycinium (PubChem CID: 248)
- 86. Nicotine (PubChem CID: 89594)
- 87. Notoamide A (PubChem CID: 16128040)
- 88. Notoamide B (PubChem CID: 16127923)
- 89. Notoamide D (PubChem CID: 16127841)
- 90. Notoamide F (PubChem CID: 25180710)
- 91. Notoamide G (PubChem CID: 25180707)
- 92. Notoamide H (PubChem CID: 25180895)
- 93. Notoamide I (PubChem CID: 25180708)
- 94. Notoamide J (PubChem CID: 25180709)
- 95. Notoamide K (PubChem CID: 25180896)
- 96. Notoamide O (PubChem CID: 102043608)
- 97. Notoamide P (PubChem CID: 46919486)
- 98. Notoamide Q (PubChem CID: 46919487)
- 99. Notoamide R (PubChem CID: 46919488)
- 100. Nv766twa77 (PubChem CID: 102146782)
- 101. Palmitic Acid (PubChem CID: 985)
- 102. Pectenol A/(Pectenol) (PubChem CID: 16061215)
- 103. Piperonal (PubChem CID: 8438)
- 104. Piperyline (PubChem CID: 636537)
- 105. Primulagenin A (PubChem CID: 10004345)
- 106. Retrofractamide A (PubChem CID: 11012859)
- 107. Sclerotiamide (PubChem CID: 10647785)
- 108. Spathulenol (PubChem CID: 92231)
- 109. Sucutinirane F (PubChem CID: 44139375)
- 1. Alzheimer's Disease 1
- 2. Arthritis, Rheumatoid
- 3. Asthma
- 4. Cardiovascular Diseases
- 5. Cataract
- 6. Celiac Disease
- 7. Coronary Artery Disease
- 8. Coronary Disease
- 9. Crohn Disease
- 10. Cystic Fibrosis
- 11. Dental Caries
- 12. Diabetes Mellitus
- 13. Muscular Dystrophies
- 14. Myocardial Infarction
- 15. Myocardial Ischemia
- 16. Obesity
- 17. Pre-Eclampsia
- 18. Psoriasis
- 19. Urinary Tract Infections
Not listed in any formulations.